No headlines found.
Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600
PRNewswire (Mon, 20-Jul 5:43 PM ET)
Taylor Morrison Announces Consent Solicitations
PRNewswire (Thu, 16-Jul 8:15 AM ET)
Business Wire (Mon, 13-Jul 1:31 PM ET)
Taylor Morrison Ranks as Top Homebuilder on TIME's America's Best Companies 2026
PRNewswire (Mon, 13-Jul 6:03 AM ET)
Are AVB, LPRO, APGE, TMHC Obtaining Fair Deals for their Shareholders?
PRNewswire (Mon, 6-Jul 8:02 PM ET)
PRNewswire (Mon, 6-Jul 2:18 PM ET)
Globe Newswire (Tue, 30-Jun 2:50 PM ET)
Are NUVL, CPRX, TMHC Obtaining Fair Deals for their Shareholders?
PRNewswire (Thu, 25-Jun 1:57 PM ET)
PRNewswire (Wed, 24-Jun 3:36 PM ET)
Globe Newswire (Mon, 15-Jun 4:06 PM ET)
Taylor Morrison Home Corp is an American residential construction company engaged in residential homebuilding and the development of lifestyle communities. It designs, builds, and sells single and multi-family detached and attached homes in traditionally high growth markets for entry level, move-up, and resort lifestyle buyers. The company has four reportable segments: East, Central, West, and Financial Services. The majority of the company's revenue is derived from its West Segment.
Taylor Morrison Home trades on the NYSE stock market under the symbol TMHC.
As of August 3, 2026, TMHC stock price was flat at $72.45 with million shares trading.
TMHC has a beta of 0.37, meaning it tends to be less sensitive to market movements. TMHC has a correlation of 0.02 to the broad based SPY ETF.
TMHC has a market cap of $6.67 billion. This is considered a Mid Cap stock.
Last quarter Taylor Morrison Home reported $1 billion in Revenue and $1.12 earnings per share. This beat revenue expectation by $59 million and exceeded earnings estimates by $.29.
In the last 3 years, TMHC traded as high as $75.49 and as low as $37.23.
The top ETF exchange traded funds that TMHC belongs to (by Net Assets): VTI, VB, VBR, VXF, VTWO.
TMHC has outperformed the market in the last year with a return of +22.2%, while the SPY ETF gained +20.8%. In the last 3 month period, TMHC beat the market returning +19.3%, while SPY returned +5.5%. However, in the most recent 2 weeks TMHC has underperformed the stock market by returning +0.4%, while SPY returned +1.7%.
TMHC support price is $72.35 and resistance is $72.55 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TMHC shares will trade within this expected range on the day.